India Globalization Capital, Inc. (NYSEAMERICAN:IGC) shares saw an uptick in trading volume on Wednesday . 2,321,409 shares changed hands during trading, an increase of 277% from the previous session’s volume of 616,191 shares.The stock last traded at $0.78 and had previously closed at $0.65.
India Globalization Capital (NYSEAMERICAN:IGC) last released its quarterly earnings results on Wednesday, November 6th. The construction company reported ($0.03) earnings per share (EPS) for the quarter. The firm had revenue of $1.82 million during the quarter.
Several large investors have recently added to or reduced their stakes in the company. Citadel Advisors LLC purchased a new stake in India Globalization Capital during the 2nd quarter worth about $65,000. Northern Trust Corp purchased a new stake in India Globalization Capital during the 2nd quarter worth about $68,000. Jane Street Group LLC increased its position in India Globalization Capital by 308.2% during the 2nd quarter. Jane Street Group LLC now owns 44,782 shares of the construction company’s stock worth $73,000 after purchasing an additional 33,811 shares in the last quarter. Anson Funds Management LP purchased a new stake in India Globalization Capital during the 2nd quarter worth about $155,000. Finally, Vanguard Group Inc. purchased a new stake in India Globalization Capital during the 2nd quarter worth about $745,000.
About India Globalization Capital (NYSEAMERICAN:IGC)
India Globalization Capital, Inc engages in the development and commercialization of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company operates through two segments, Legacy Infrastructure and Medical Cannabis Based Alternative Therapies.
See Also: Trade War
Receive News & Ratings for India Globalization Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for India Globalization Capital and related companies with MarketBeat.com's FREE daily email newsletter.